Insurance coverage, personal healthcare spending, longevity, mortality, health risks, and provider shortages.
Uninsured rate · all ages6.9%2024 · #27 of 50 · highest first
Uninsured rate · under age 658.5%2024 · #26 of 50 · highest first
Private coverage · under age 6571.3%2024 · #27 of 50 · highest first
Delaware over time
Explore Delaware readings, major events and reviewed actions on the same date scale. Delaware officeholders appear in separate lanes. National event evidence describes national context; it does not measure a Delaware effect.
Major events & context · A curated selection, including uncertain effects. Milestone dates do not establish that an event caused a Delaware change.
Enacted / issuedDid not proceedPending / in progressStatus unclear
Colors show the latest recorded status. Passing one chamber is not enactment. A number groups actions with the same date, body and status.
Uninsured rate · all ages Delaware · source units
DelawarePublished U.S. benchmark
Move across the chart to inspect the nearest observation. Click or tap to keep a reading selected, or focus the chart and use the arrow keys. Hover over or focus a marker to explore; click or tap to pin. Press Escape to clear.
14 of 14 reviewed Delaware actions match · 13 date markers shown. 31 major events shown separately.
Delaware · 2024: 6.9% · Rank #27 of 50, highest first · U.S. benchmark: 8.2%
FactVote uses the Census Bureau's HIC-4_ACS historical table. Rates and 90% confidence margins of error are the published ACS 1-year estimates for the civilian noninstitutionalized population. ACS annual estimates, all ages. Standard ACS 2020 one-year data were not released; the chart leaves a gap. Survey ranks describe point estimates and do not establish significant differences. Annual observations use December 31; monthly observations use the first of the month. Lines connect consecutive readings and do not supply values between them. Missing observations break the lines.
The timeline combines the corresponding national fact’s reviewed event catalog, labeled National context, with individually reviewed state milestones. State events use primary sources and distinguish signing, effective and filing dates. Each milestone keeps its source-check date, geographical limits and evidence limits. This curated selection is not a complete history.
Date ranges affect events and actions. Action type, status and official-name search affect government records only. Events remain separate from action counts. An event after the latest observation extends context without creating a new reading.
Delaware · state comparison
Who has health coverage?
Compare ACS annual estimates for all ages or people under 65. Coverage categories can overlap and do not sum to the insured share.
Delaware · 20246.9%
Delaware rank#27among all 50 states
U.S. benchmark8.2%Same measure and period when published
#1 is the highest value. Ties share a rank and leave gaps. D.C. and territories are excluded. Rank describes the measured value; it is not an overall score of the state.
Uninsured rate · all ages
FactVote uses the Census Bureau's HIC-4_ACS historical table. Rates and 90% confidence margins of error are the published ACS 1-year estimates for the civilian noninstitutionalized population.
ACS annual estimates, all ages. Standard ACS 2020 one-year data were not released; the chart leaves a gap. Survey ranks describe point estimates and do not establish significant differences.
Hover to inspect. Click or tap to compare that period with every state. Focus the graph and use arrow keys, Home or End to select a period. Press Escape to return to the latest period.
Delaware
2024 · Delaware: 6.9% · Rank #27 of 50, highest first · U.S. benchmark: 8.2% · Selected for state comparisonView history and select a period
Delaware Uninsured rate · all ages history
Period
Delaware
Compare
2014
7.8%
2015
5.9%
2016
5.7%
2017
5.4%
2018
5.7%
2019
6.6%
2020
Not available
2021
5.7%
2022
5.6%
2023
6.5%
2024
6.9%
Compare states on the graph
Hover or focus a bar to inspect its value and rank. Use the up and down arrows, Home or End to explore states. Click, tap or press Enter to keep a state selected. Delaware stays highlighted. Values use the same measure and period.
Explore the map: hover or focus a state to inspect it, then click or tap to select it. Arrow keys move between states alphabetically. Delaware has a dark outline.
Lower value · 2.8%Higher value · 16.7%Striped: unavailable
Color shows this measure’s value, not an overall state score. Select a state on the map, graph or dropdown to read its value, rank and comparison limits below.
Delaware · 6.9%2024 · Rank #27 of 50, highest firstSelected state
50 states shown · scroll to explore every state. Missing values have no bar and are excluded from ranks. Bars start at zero; #1 means the highest value.
Compare Delaware with every state · 50 ranked
Uninsured rate · all ages · 2024 · highest value ranked #1
Rank
State
Value
Comparison notes
#1
Texas
16.7%
—
#2
Georgia
12%
—
#3
Oklahoma
11.5%
—
#4
Nevada
11.4%
—
#5
Alaska
11%
—
#6
Florida
10.9%
—
#7
Arizona
10.3%
—
#7
Wyoming
10.3%
—
#9
New Mexico
10.1%
—
#10
Mississippi
9.7%
—
#10
Tennessee
9.7%
—
#12
Arkansas
9.4%
—
#13
Idaho
9.2%
—
#14
South Carolina
9%
—
#15
Montana
8.8%
—
#16
North Carolina
8.6%
—
#17
Kansas
8.5%
—
#18
Utah
8.3%
—
#19
Alabama
8.2%
—
#20
South Dakota
8.1%
—
#21
Colorado
7.9%
—
#22
Louisiana
7.7%
—
#22
Missouri
7.7%
—
#22
New Jersey
7.7%
—
#25
Indiana
7.5%
—
#26
Nebraska
7.1%
—
#27
Delaware · your comparison
6.9%
—
#27
Illinois
6.9%
—
#27
Virginia
6.9%
—
#30
Kentucky
6.8%
—
#31
Ohio
6.7%
—
#32
Washington
6.5%
—
#33
Maryland
6.3%
—
#34
North Dakota
6.1%
—
#35
California
5.9%
—
#36
Connecticut
5.8%
—
#36
Pennsylvania
5.8%
—
#36
West Virginia
5.8%
—
#39
Maine
5.5%
—
#40
Iowa
5.4%
—
#41
Wisconsin
5.3%
—
#42
Oregon
5.2%
—
#43
Michigan
5.1%
—
#43
Minnesota
5.1%
—
#45
New York
5%
—
#46
Rhode Island
4.6%
—
#47
New Hampshire
4.5%
—
#48
Vermont
4.2%
—
#49
Hawaii
3.5%
—
#50
Massachusetts
2.8%
—
All 50 states are listed, including states without a comparable observation. Ranks use stored source precision; displayed values may round to the same number.
Share of Delaware’s civilian noninstitutionalized residents under age 65 who lacked comprehensive health-insurance coverage at the time of the ACS survey.
This source snapshot keeps its own definition and period. A rank shown elsewhere applies only to that comparison’s measure and period.
Method and limitations
U.S. Census Bureau QuickFacts, sourced from the 2024 American Community Survey 1-year estimate.
This is a survey estimate for people under 65 and does not describe coverage type or continuity of coverage.
Insurance status alone does not measure affordability, access, quality, or health outcomes.
State spending is reported for 2020, the latest year available in this CMS state series. Choose a service to compare Delaware with every state.
Delaware · 2020$12,899
Delaware rank#4among all 50 states
U.S. benchmark$10,191Same measure and period when published
#1 is the highest value. Ties share a rank and leave gaps. D.C. and territories are excluded. Rank describes the measured value; it is not an overall score of the state.
Personal healthcare spending per resident
Personal health care expenditure per resident, assigned to the state where the patient resides.
2020 is the last year in this CMS state series. Personal health care excludes administration, public health, and investment included in national health expenditures. This is spending by all payers, not a household bill.
Hover to inspect. Click or tap to compare that period with every state. Focus the graph and use arrow keys, Home or End to select a period. Press Escape to return to the latest period.
Delaware
2020 · Delaware: $12,899 · Rank #4 of 50, highest first · U.S. benchmark: $10,191 · Selected for state comparisonView history and select a period
Delaware Personal healthcare spending per resident history
Period
Delaware
Compare
2014
$10,263
2015
$10,714
2016
$10,933
2017
$11,444
2018
$11,771
2019
$12,213
2020
$12,899
Compare states on the graph
Hover or focus a bar to inspect its value and rank. Use the up and down arrows, Home or End to explore states. Click, tap or press Enter to keep a state selected. Delaware stays highlighted. Values use the same measure and period.
Explore the map: hover or focus a state to inspect it, then click or tap to select it. Arrow keys move between states alphabetically. Delaware has a dark outline.
Lower value · $7.52KHigher value · $14.01KStriped: unavailable
Color shows this measure’s value, not an overall state score. Select a state on the map, graph or dropdown to read its value, rank and comparison limits below.
Delaware · $12,8992020 · Rank #4 of 50, highest firstSelected state
50 states shown · scroll to explore every state. Missing values have no bar and are excluded from ranks. Bars start at zero; #1 means the highest value.
Compare Delaware with every state · 50 ranked
Personal healthcare spending per resident · 2020 · highest value ranked #1
Rank
State
Value
Comparison notes
#1
New York
$14,007
—
#2
Alaska
$13,642
—
#3
Massachusetts
$13,319
—
#4
Delaware · your comparison
$12,899
—
#5
West Virginia
$12,769
—
#6
Vermont
$12,756
—
#7
South Dakota
$12,495
—
#8
Connecticut
$12,489
—
#9
Maine
$12,077
—
#10
New Jersey
$11,868
—
#11
New Hampshire
$11,793
—
#12
Rhode Island
$11,694
—
#13
Pennsylvania
$11,603
—
#14
North Dakota
$11,301
—
#15
Wyoming
$10,989
—
#16
Minnesota
$10,846
—
#17
Maryland
$10,839
—
#18
Indiana
$10,517
—
#19
Louisiana
$10,515
—
#20
Nebraska
$10,514
—
#21
Ohio
$10,478
—
#22
California
$10,299
—
#23
Hawaii
$10,291
—
#24
Kentucky
$10,257
—
#25
Montana
$10,212
—
#26
Illinois
$10,190
—
#27
Oregon
$10,071
—
#28
Wisconsin
$9,982
—
#29
Missouri
$9,921
—
#30
Michigan
$9,897
—
#31
Florida
$9,865
—
#32
Iowa
$9,789
—
#33
Oklahoma
$9,444
—
#34
Kansas
$9,408
—
#35
Mississippi
$9,394
—
#36
Arkansas
$9,338
—
#37
Tennessee
$9,336
—
#38
Alabama
$9,280
—
#39
Washington
$9,265
—
#40
Virginia
$9,195
—
#41
North Carolina
$8,917
—
#42
New Mexico
$8,902
—
#43
South Carolina
$8,766
—
#44
Georgia
$8,758
—
#45
Arizona
$8,756
—
#46
Colorado
$8,583
—
#47
Texas
$8,406
—
#48
Nevada
$8,348
—
#49
Idaho
$8,148
—
#50
Utah
$7,522
—
All 50 states are listed, including states without a comparable observation. Ranks use stored source precision; displayed values may round to the same number.
Use age-adjusted mortality to account for different age distributions; life expectancy summarizes period death rates.
Delaware · 202276.5 years
Delaware rank#32among all 50 states
U.S. benchmark77.5 yearsSame measure and period when published
#1 is the highest value. Ties share a rank and leave gaps. D.C. and territories are excluded. Rank describes the measured value; it is not an overall score of the state.
Life expectancy at birth
FactVote uses CDC National Center for Health Statistics annual complete life-table estimates for the total Delaware population. Values are rounded to the published tenth of a year.
The latest published comparable state series ends in 2022, even though newer national life-expectancy estimates may be available. Period life expectancy summarizes current mortality rates; it is not a forecast of how long a particular person will live. The 2020 and 2021 estimates reflect the mortality shock during the COVID-19 pandemic.
Hover to inspect. Click or tap to compare that period with every state. Focus the graph and use arrow keys, Home or End to select a period. Press Escape to return to the latest period.
Delaware
2022 · Delaware: 76.5 years · Rank #32 of 50, highest first · U.S. benchmark: 77.5 years · Selected for state comparisonView history and select a period
Delaware Life expectancy at birth history
Period
Delaware
Compare
2018
77.8 years
2019
78.1 years
2020
76.7 years
2021
76.3 years
2022
76.5 years
Compare states on the graph
Hover or focus a bar to inspect its value and rank. Use the up and down arrows, Home or End to explore states. Click, tap or press Enter to keep a state selected. Delaware stays highlighted. Values use the same measure and period.
Explore the map: hover or focus a state to inspect it, then click or tap to select it. Arrow keys move between states alphabetically. Delaware has a dark outline.
Lower value · 72.2 yearsHigher value · 80 yearsStriped: unavailable
Color shows this measure’s value, not an overall state score. Select a state on the map, graph or dropdown to read its value, rank and comparison limits below.
Delaware · 76.5 years2022 · Rank #32 of 50, highest firstSelected state
50 states shown · scroll to explore every state. Missing values have no bar and are excluded from ranks. Bars start at zero; #1 means the highest value.
Compare Delaware with every state · 50 ranked
Life expectancy at birth · 2022 · highest value ranked #1
Rank
State
Value
Comparison notes
#1
Hawaii
80 years
—
#2
Massachusetts
79.8 years
—
#3
New Jersey
79.6 years
—
#4
New York
79.5 years
—
#5
Connecticut
79.4 years
—
#6
California
79.3 years
—
#6
Minnesota
79.3 years
—
#8
Rhode Island
79.2 years
—
#9
Utah
79 years
—
#10
New Hampshire
78.7 years
—
#11
Colorado
78.5 years
—
#12
Idaho
78.4 years
—
#12
Washington
78.4 years
—
#14
Nebraska
78.3 years
—
#14
Vermont
78.3 years
—
#16
Wisconsin
78.1 years
—
#17
Florida
77.9 years
—
#17
Iowa
77.9 years
—
#17
North Dakota
77.9 years
—
#20
Maryland
77.8 years
—
#21
Oregon
77.7 years
—
#22
Illinois
77.5 years
—
#22
Virginia
77.5 years
—
#24
Montana
77.3 years
—
#24
Pennsylvania
77.3 years
—
#24
South Dakota
77.3 years
—
#27
Texas
77.1 years
—
#28
Michigan
76.8 years
—
#28
Wyoming
76.8 years
—
#30
Arizona
76.7 years
—
#31
Maine
76.6 years
—
#32
Delaware · your comparison
76.5 years
—
#32
Kansas
76.5 years
—
#34
Nevada
76.4 years
—
#35
Georgia
75.9 years
—
#35
North Carolina
75.9 years
—
#37
Alaska
75.8 years
—
#38
Ohio
75.6 years
—
#39
Indiana
75.4 years
—
#40
Missouri
75.2 years
—
#41
South Carolina
75.1 years
—
#42
New Mexico
74.5 years
—
#43
Arkansas
73.9 years
—
#44
Alabama
73.8 years
—
#44
Louisiana
73.8 years
—
#44
Oklahoma
73.8 years
—
#44
Tennessee
73.8 years
—
#48
Kentucky
73.6 years
—
#49
Mississippi
72.6 years
—
#50
West Virginia
72.2 years
—
All 50 states are listed, including states without a comparable observation. Ranks use stored source precision; displayed values may round to the same number.
Compare age-adjusted adult prevalence using the same survey year and definition.
Delaware · 202311.1%
Delaware rank#13among 48 states with data
U.S. benchmark10.7%Same measure and period when published
#1 is the highest value. Ties share a rank and leave gaps. D.C. and territories are excluded. Rank describes the measured value; it is not an overall score of the state.
Diagnosed diabetes · age adjusted
Adult self-reported prevalence, age-adjusted to a common population.
Published CDC 2019–2023 series. Missing or suppressed estimates remain unranked. Confidence intervals describe sampling uncertainty; point ranks are not significance tests.
Hover to inspect. Click or tap to compare that period with every state. Focus the graph and use arrow keys, Home or End to select a period. Press Escape to return to the latest period.
Delaware
2023 · Delaware: 11.1% · Rank #13 of 48, highest first · U.S. benchmark: 10.7% · Selected for state comparisonView history and select a period
Delaware Diagnosed diabetes · age adjusted history
Period
Delaware
Compare
2019
11%
2020
10.6%
2021
10%
2022
11.9%
2023
11.1%
Compare states on the graph
Hover or focus a bar to inspect its value and rank. Use the up and down arrows, Home or End to explore states. Click, tap or press Enter to keep a state selected. Delaware stays highlighted. Values use the same measure and period.
Explore the map: hover or focus a state to inspect it, then click or tap to select it. Arrow keys move between states alphabetically. Delaware has a dark outline.
Lower value · 7.8%Higher value · 15.1%Striped: unavailable
Color shows this measure’s value, not an overall state score. Select a state on the map, graph or dropdown to read its value, rank and comparison limits below.
Delaware · 11.1%2023 · Rank #13 of 48, highest first95% confidence interval: 9.8% – 12.6%Selected state
50 states shown · scroll to explore every state. Missing values have no bar and are excluded from ranks. Bars start at zero; #1 means the highest value.
Compare Delaware with every state · 48 ranked, 2 unavailable
Diagnosed diabetes · age adjusted · 2023 · highest value ranked #1
Rank
State
Value
Comparison notes
#1
Mississippi
15.1%
95% CI: 13.7–16.6
#1
West Virginia
15.1%
95% CI: 13.9–16.3
#3
Louisiana
14.6%
95% CI: 13.4–15.8
#4
Alabama
14%
95% CI: 12.7–15.3
#5
Arkansas
13.1%
95% CI: 12–14.3
#6
South Carolina
12.7%
95% CI: 11.9–13.6
#6
Tennessee
12.7%
95% CI: 11.7–13.8
#8
Texas
12.1%
95% CI: 11–13.3
#9
Indiana
11.7%
95% CI: 11.1–12.4
#10
Georgia
11.5%
95% CI: 10.7–12.3
#10
Ohio
11.5%
95% CI: 10.8–12.2
#12
Oklahoma
11.3%
95% CI: 10.5–12.1
#13
Delaware · your comparison
11.1%
95% CI: 9.8–12.6
#14
North Carolina
11%
95% CI: 9.8–12.3
#15
Illinois
10.9%
95% CI: 9.9–12.1
#15
Maryland
10.9%
95% CI: 10.2–11.7
#15
Michigan
10.9%
95% CI: 10.1–11.8
#18
Nevada
10.8%
95% CI: 8.9–13
#18
New Mexico
10.8%
95% CI: 9.3–12.6
#20
Missouri
10.7%
95% CI: 9.9–11.7
#20
South Dakota
10.7%
95% CI: 8.9–12.8
#22
California
10.6%
95% CI: 9.8–11.4
#23
Kansas
10.5%
95% CI: 9.7–11.3
#24
Virginia
10.4%
95% CI: 9.5–11.4
#25
Florida
10.1%
95% CI: 9.1–11.1
#26
Rhode Island
10%
95% CI: 9.1–11
#27
Arizona
9.9%
95% CI: 9.2–10.7
#27
Iowa
9.9%
95% CI: 9.2–10.7
#29
Nebraska
9.7%
95% CI: 9–10.3
#30
Wisconsin
9.6%
95% CI: 9–10.2
#31
Hawaii
9.5%
95% CI: 8.7–10.5
#31
New York
9.5%
95% CI: 8.9–10.1
#31
Oregon
9.5%
95% CI: 8.7–10.5
#34
Wyoming
9.4%
95% CI: 8.5–10.5
#35
Minnesota
9.3%
95% CI: 8.6–10
#36
New Jersey
9.1%
95% CI: 8.4–9.9
#37
Maine
9%
95% CI: 8.4–9.7
#38
North Dakota
8.9%
95% CI: 8.1–9.7
#39
Idaho
8.7%
95% CI: 7.9–9.6
#40
Washington
8.6%
95% CI: 8.2–9
#41
Massachusetts
8.5%
95% CI: 7.8–9.4
#42
Connecticut
8.4%
95% CI: 7.6–9.3
#43
Alaska
8.2%
95% CI: 7.4–9.2
#44
Utah
8.1%
95% CI: 7.5–8.7
#45
Colorado
8%
95% CI: 7.3–8.7
#46
Montana
7.9%
95% CI: 7.2–8.7
#46
New Hampshire
7.9%
95% CI: 7.1–8.8
#48
Vermont
7.8%
95% CI: 7–8.7
—
Kentucky
Not available
No comparable published observation for this period; excluded from rank.
—
Pennsylvania
Not available
No comparable published observation for this period; excluded from rank.
All 50 states are listed, including states without a comparable observation. Ranks use stored source precision; displayed values may round to the same number.
Compare coverage of need, practitioners needed, or affected population for each discipline.
Delaware · June 30, 202611.2%
Delaware rank#50among all 50 states
U.S. benchmark47.4%Same measure and period when published
#1 is the highest value. Ties share a rank and leave gaps. D.C. and territories are excluded. Rank describes the measured value; it is not an overall score of the state.
Primary care · need met
HRSA-designated shortage areas; measures describe need within those areas, not the entire state population.
National report totals can include territories. Designation rules and populations differ by discipline; do not add disciplines. Absolute population and practitioner ranks also reflect state size.
Compare states on the graph
Hover or focus a bar to inspect its value and rank. Use the up and down arrows, Home or End to explore states. Click, tap or press Enter to keep a state selected. Delaware stays highlighted. Values use the same measure and period.
Explore the map: hover or focus a state to inspect it, then click or tap to select it. Arrow keys move between states alphabetically. Delaware has a dark outline.
Lower value · 11.2%Higher value · 83.2%Striped: unavailable
Color shows this measure’s value, not an overall state score. Select a state on the map, graph or dropdown to read its value, rank and comparison limits below.
Delaware · 11.2%June 30, 2026 · Rank #50 of 50, highest firstSelected state
50 states shown · scroll to explore every state. Missing values have no bar and are excluded from ranks. Bars start at zero; #1 means the highest value.
Compare Delaware with every state · 50 ranked
Primary care · need met · June 30, 2026 · highest value ranked #1
Rank
State
Value
Comparison notes
#1
New Jersey
83.2%
—
#2
Vermont
82.6%
—
#3
South Carolina
79.4%
—
#4
New Hampshire
74.8%
—
#5
Rhode Island
74.3%
—
#6
Louisiana
72.1%
—
#7
Hawaii
67.1%
—
#8
Utah
65.4%
—
#9
Wisconsin
65.2%
—
#10
Alabama
63%
—
#11
Connecticut
60.3%
—
#12
Massachusetts
58%
—
#13
Tennessee
58%
—
#14
Virginia
57.2%
—
#15
Pennsylvania
56.7%
—
#16
Maine
56%
—
#17
Minnesota
55.4%
—
#18
Wyoming
54.4%
—
#19
Indiana
54.2%
—
#20
California
53.2%
—
#21
Arkansas
52.6%
—
#22
Texas
49.8%
—
#23
Ohio
49.7%
—
#24
Nebraska
49.1%
—
#25
Alaska
48.9%
—
#26
North Carolina
48.1%
—
#27
Colorado
47.5%
—
#28
Michigan
44.9%
—
#29
Oregon
43.9%
—
#30
Idaho
43.9%
—
#31
Washington
42.4%
—
#32
Illinois
41.5%
—
#33
Nevada
41.5%
—
#34
Arizona
41.2%
—
#35
Kansas
41.1%
—
#36
Iowa
40.5%
—
#37
Florida
39.7%
—
#38
Georgia
39.1%
—
#39
Montana
38.5%
—
#40
West Virginia
38.3%
—
#41
North Dakota
36.5%
—
#42
New York
35.3%
—
#43
South Dakota
34.6%
—
#44
Mississippi
34.1%
—
#45
Maryland
31.6%
—
#46
New Mexico
31.4%
—
#47
Kentucky
30.8%
—
#48
Oklahoma
28.6%
—
#49
Missouri
23.7%
—
#50
Delaware · your comparison
11.2%
—
All 50 states are listed, including states without a comparable observation. Ranks use stored source precision; displayed values may round to the same number.
Premium comparisons use a published historical all-state employer survey. Total premiums combine employer and employee payments.
Delaware · 2020$7,280
Delaware rank#18among all 50 states
U.S. benchmark$7,149Same measure and period when published
#1 is the highest value. Ties share a rank and leave gaps. D.C. and territories are excluded. Rank describes the measured value; it is not an overall score of the state.
Single coverage premium · all firms
Average total annual employer-plan premium per enrolled employee at private-sector establishments offering coverage.
Historical 2020 published all-state table; not a current quote. Includes both employer and employee contributions, rather than just a worker’s payment. Survey estimates and small firm samples carry uncertainty. Missing estimates remain unavailable.
Compare states on the graph
Hover or focus a bar to inspect its value and rank. Use the up and down arrows, Home or End to explore states. Click, tap or press Enter to keep a state selected. Delaware stays highlighted. Values use the same measure and period.
Explore the map: hover or focus a state to inspect it, then click or tap to select it. Arrow keys move between states alphabetically. Delaware has a dark outline.
Lower value · $6.39KHigher value · $8.64KStriped: unavailable
Color shows this measure’s value, not an overall state score. Select a state on the map, graph or dropdown to read its value, rank and comparison limits below.
Delaware · $7,2802020 · Rank #18 of 50, highest firstSelected state
50 states shown · scroll to explore every state. Missing values have no bar and are excluded from ranks. Bars start at zero; #1 means the highest value.
Compare Delaware with every state · 50 ranked
Single coverage premium · all firms · 2020 · highest value ranked #1
Rank
State
Value
Comparison notes
#1
Alaska
$8,635
—
#2
New York
$8,177
—
#3
New Hampshire
$7,991
—
#4
Vermont
$7,868
—
#5
Wyoming
$7,743
—
#6
Nebraska
$7,611
—
#7
South Carolina
$7,516
—
#8
Connecticut
$7,501
—
#9
Maine
$7,496
—
#10
Massachusetts
$7,452
—
#11
Washington
$7,440
—
#12
New Mexico
$7,424
—
#13
Illinois
$7,376
—
#14
New Jersey
$7,373
—
#15
Maryland
$7,352
—
#16
Rhode Island
$7,326
—
#17
Indiana
$7,319
—
#18
Delaware · your comparison
$7,280
—
#19
Wisconsin
$7,250
—
#20
Pennsylvania
$7,246
—
#21
North Dakota
$7,216
—
#22
Colorado
$7,206
—
#23
Missouri
$7,179
—
#24
California
$7,173
—
#25
Florida
$7,078
—
#26
South Dakota
$7,070
—
#27
Oklahoma
$7,058
—
#28
Hawaii
$7,040
—
#29
North Carolina
$7,036
—
#30
Texas
$7,017
—
#31
West Virginia
$6,993
—
#32
Ohio
$6,989
—
#33
Kentucky
$6,949
—
#34
Iowa
$6,932
—
#35
Virginia
$6,928
—
#36
Oregon
$6,917
—
#37
Minnesota
$6,910
—
#38
Georgia
$6,876
—
#39
Montana
$6,860
—
#40
Idaho
$6,744
—
#41
Louisiana
$6,713
—
#42
Michigan
$6,683
—
#43
Kansas
$6,675
—
#44
Arizona
$6,612
—
#45
Utah
$6,593
—
#46
Mississippi
$6,561
—
#47
Nevada
$6,493
—
#48
Tennessee
$6,485
—
#49
Arkansas
$6,414
—
#50
Alabama
$6,393
—
All 50 states are listed, including states without a comparable observation. Ranks use stored source precision; displayed values may round to the same number.
Adult statewide estimates use the same SAMHSA model and survey period. Treatment use is a share of all adults, not a share of adults with mental illness.
Delaware · 2023–202422.1%
Delaware rank#40among all 50 states
U.S. benchmark23.1%Same measure and period when published
#1 is the highest value. Ties share a rank and leave gaps. D.C. and territories are excluded. Rank describes the measured value; it is not an overall score of the state.
Any Mental Illness · adults 18+
Civilian noninstitutionalized adults age 18+, past-year prevalence or treatment use, estimated by small-area survey models.
Mental illness and depression estimates pool 2023–2024; treatment use covers 2024 only. Definitions and model-based uncertainty differ from the national page’s annual 2025 survey estimates. Point-estimate ranks do not establish significant differences. Serious mental illness is a subset of any mental illness, so their percentages must not be added.
Compare states on the graph
Hover or focus a bar to inspect its value and rank. Use the up and down arrows, Home or End to explore states. Click, tap or press Enter to keep a state selected. Delaware stays highlighted. Values use the same measure and period.
Explore the map: hover or focus a state to inspect it, then click or tap to select it. Arrow keys move between states alphabetically. Delaware has a dark outline.
Lower value · 18.1%Higher value · 31.6%Striped: unavailable
Color shows this measure’s value, not an overall state score. Select a state on the map, graph or dropdown to read its value, rank and comparison limits below.
Delaware · 22.1%2023–2024 · Rank #40 of 50, highest firstSelected state
50 states shown · scroll to explore every state. Missing values have no bar and are excluded from ranks. Bars start at zero; #1 means the highest value.
Compare Delaware with every state · 50 ranked
Any Mental Illness · adults 18+ · 2023–2024 · highest value ranked #1
Rank
State
Value
Comparison notes
#1
Oregon
31.6%
—
#2
Vermont
29.1%
—
#3
West Virginia
28.1%
—
#4
Washington
27.9%
—
#5
New Hampshire
27.7%
—
#6
Tennessee
27%
—
#7
Utah
26.7%
—
#8
Maine
26.7%
—
#9
Arkansas
26.6%
—
#10
Colorado
26.4%
—
#11
Rhode Island
25.8%
—
#12
Missouri
25.7%
—
#13
Montana
25.6%
—
#14
Indiana
25.3%
—
#15
Kentucky
25.3%
—
#16
Georgia
25.2%
—
#17
Iowa
25%
—
#18
Massachusetts
24.9%
—
#19
Wyoming
24.7%
—
#20
Nevada
24.6%
—
#21
Arizona
24.6%
—
#22
Wisconsin
24.6%
—
#23
Idaho
24.5%
—
#24
Nebraska
24.1%
—
#25
Louisiana
24.1%
—
#26
Alaska
24%
—
#27
Pennsylvania
23.9%
—
#28
New Mexico
23.9%
—
#28
Ohio
23.9%
—
#30
Connecticut
23.7%
—
#31
Kansas
23.7%
—
#32
Michigan
23.6%
—
#33
Virginia
23.1%
—
#34
Alabama
23%
—
#35
North Dakota
23%
—
#36
Maryland
22.7%
—
#37
Oklahoma
22.6%
—
#38
Minnesota
22.6%
—
#39
Illinois
22.2%
—
#40
Delaware · your comparison
22.1%
—
#41
New York
21.9%
—
#42
South Dakota
21.8%
—
#43
California
21.6%
—
#44
North Carolina
21.4%
—
#45
Florida
20.8%
—
#46
Texas
20.7%
—
#47
Mississippi
20.5%
—
#48
Hawaii
19.8%
—
#49
South Carolina
19.8%
—
#50
New Jersey
18.1%
—
All 50 states are listed, including states without a comparable observation. Ranks use stored source precision; displayed values may round to the same number.
Explore current officeholders and explicitly reviewed historical executive officials, labeled at the time of their actions. Timeline dates, action type, status and search also filter this list. Read any record’s summary, latest recorded status and official evidence below, or open it beside the timeline.
14 of 14 reviewed Delaware actions · newest first
Sep 30, 2026 · Executive Order #28 · Delaware orders phased harm-reduction licensing and evaluation · Order issued; historical provisionsGovernor · Executive Order #28
Delaware orders phased harm-reduction licensing and evaluation
Sep 30, 2026 · Order issued; historical provisions
Gov. Matt Meyer · Issued
Reviewed original executive order
Directs DHSS and DSAMH to develop evidence-based harm-reduction licensing regulations, phase existing services into licensing, establish baseline and outcome monitoring, and evaluate both the programs and the statutory paraphernalia changes. Expansion of state funding for emerging-evidence supplies requires a written finding of positive results without significant unintended harm and stakeholder consultation. Requires public evaluation reporting within 12 months after the regulations take effect and annually thereafter. Administrative program components may be paused or changed under the stated evidence standard, but the statutory removal of personal-use paraphernalia penalties can be altered only by legislation. Coordination with SS 1 for SB 161, applicable law, privacy protections and availability of appropriations remain conditions. Regulations, actual licenses and measured outcomes are not established by issuance. Expansion of state funding for emerging-evidence supplies requires a written finding and consultation. Reporting runs from the regulations’ effective date. Administrative program changes cannot undo the statute’s removal of personal-use paraphernalia penalties. Regulations, licensed providers and measured outcomes remain to be verified.
Issued 2026-09-30. Expansion of state funding for emerging-evidence supplies requires a written finding and consultation. Reporting runs from the regulations’ effective date. Administrative program changes cannot undo the statute’s removal of personal-use paraphernalia penalties. Regulations, licensed providers and measured outcomes remain to be verified.
Why this record is included
Directs DHSS and DSAMH to develop evidence-based harm-reduction licensing regulations, phase existing services into licensing, establish baseline and outcome monitoring, and evaluate both the programs and the statutory paraphernalia changes. Expansion of state funding for emerging-evidence supplies requires a written finding of positive results without significant unintended harm and stakeholder consultation. Requires public evaluation reporting within 12 months after the regulations take effect and annually thereafter. Administrative program components may be paused or changed under the stated evidence standard, but the statutory removal of personal-use paraphernalia penalties can be altered only by legislation. Coordination with SS 1 for SB 161, applicable law, privacy protections and availability of appropriations remain conditions. Regulations, actual licenses and measured outcomes are not established by issuance. Expansion of state funding for emerging-evidence supplies requires a written finding and consultation. Reporting runs from the regulations’ effective date. Administrative program changes cannot undo the statute’s removal of personal-use paraphernalia penalties. Regulations, licensed providers and measured outcomes remain to be verified. The chart does not isolate this action’s effect.
Retained Delaware evidence context: health · reviewed Delaware policy context · crime · reviewed Delaware policy context. This record’s connection to the topic does not establish an effect on the measured result.
twelve ( 12) months after the effective date of the regulations
Inspect this action on the timeline ↑Sep 30, 2026 · SB 249 · Delaware approves harm-reduction licensing and personal-use paraphernalia changes · Enacted · Chapter 85:536Delaware Legislature · SB 249
Delaware approves harm-reduction licensing and personal-use paraphernalia changes
Sep 30, 2026 · Enacted · Chapter 85:536
Sen. Marie Pinkney · Sponsored / Rep. Nnamdi O. Chukwuocha · Sponsored / Sen. Ray Seigfried · Co-sponsored / Sen. David P. Sokola · Co-sponsored / Sen. Laura V. Sturgeon · Co-sponsored / Rep. Alonna Berry · Co-sponsored / Rep. Stephanie T. Bolden · Co-sponsored / Rep. Kendra Johnson · Co-sponsored / Rep. Larry Lambert · Co-sponsored / Rep. Eric Morrison · Co-sponsored / Rep. DeShanna U Neal · Co-sponsored / Rep. Cyndie Romer · Co-sponsored / Rep. Kamela T Smith · Co-sponsored
Reviewed final state legislation
Final amended SB 249, enacted as Volume 85, Chapter 536, establishes evidence-based licensing for harm-reduction providers, required supplies and services, participant anonymity, limited program data collection, referrals and conditional good-faith immunity. It revises drug-paraphernalia definitions and exempts specified personal-use, storage, testing and consumption supplies while retaining manufacturing, distribution and specified sales prohibitions. Signing and the bill page’s September 30 effective date are distinct from licensing regulations, provider licenses and service delivery. Immunity requires good faith and reasonable care and has express misconduct exceptions. Referrals do not guarantee housing, benefits or treatment, and the act does not decriminalize all drug possession or establish lower overdose deaths or crime rates.
Signed 2026-09-30. The final text establishes the licensing authority; actual regulations, licenses, program operations and outcomes require separate verification.
Why this record is included
Final amended SB 249, enacted as Volume 85, Chapter 536, establishes evidence-based licensing for harm-reduction providers, required supplies and services, participant anonymity, limited program data collection, referrals and conditional good-faith immunity. It revises drug-paraphernalia definitions and exempts specified personal-use, storage, testing and consumption supplies while retaining manufacturing, distribution and specified sales prohibitions. Signing and the bill page’s September 30 effective date are distinct from licensing regulations, provider licenses and service delivery. Immunity requires good faith and reasonable care and has express misconduct exceptions. Referrals do not guarantee housing, benefits or treatment, and the act does not decriminalize all drug possession or establish lower overdose deaths or crime rates. The chart does not isolate this action’s effect.
Retained Delaware evidence context: health · reviewed Delaware policy context · crime · reviewed Delaware policy context. This record’s connection to the topic does not establish an effect on the measured result.
A program must not require a one-for-one exchange of sterile supplies.
Inspect this action on the timeline ↑Sep 30, 2026 · SB 249 · Delaware approves harm-reduction licensing and personal-use paraphernalia changes · Signed · Chapter 85:536Governor · SB 249
Delaware approves harm-reduction licensing and personal-use paraphernalia changes
Sep 30, 2026 · Signed · Chapter 85:536
Gov. Matt Meyer · Signed
Reviewed final state legislation
Final amended SB 249, enacted as Volume 85, Chapter 536, establishes evidence-based licensing for harm-reduction providers, required supplies and services, participant anonymity, limited program data collection, referrals and conditional good-faith immunity. It revises drug-paraphernalia definitions and exempts specified personal-use, storage, testing and consumption supplies while retaining manufacturing, distribution and specified sales prohibitions. Signing and the bill page’s September 30 effective date are distinct from licensing regulations, provider licenses and service delivery. Immunity requires good faith and reasonable care and has express misconduct exceptions. Referrals do not guarantee housing, benefits or treatment, and the act does not decriminalize all drug possession or establish lower overdose deaths or crime rates.
Signed 2026-09-30. The final text establishes the licensing authority; actual regulations, licenses, program operations and outcomes require separate verification.
Why this record is included
Final amended SB 249, enacted as Volume 85, Chapter 536, establishes evidence-based licensing for harm-reduction providers, required supplies and services, participant anonymity, limited program data collection, referrals and conditional good-faith immunity. It revises drug-paraphernalia definitions and exempts specified personal-use, storage, testing and consumption supplies while retaining manufacturing, distribution and specified sales prohibitions. Signing and the bill page’s September 30 effective date are distinct from licensing regulations, provider licenses and service delivery. Immunity requires good faith and reasonable care and has express misconduct exceptions. Referrals do not guarantee housing, benefits or treatment, and the act does not decriminalize all drug possession or establish lower overdose deaths or crime rates. The chart does not isolate this action’s effect.
Retained Delaware evidence context: health · reviewed Delaware policy context · crime · reviewed Delaware policy context. This record’s connection to the topic does not establish an effect on the measured result.
A program must not require a one-for-one exchange of sterile supplies.
Inspect this action on the timeline ↑Sep 3, 2026 · HB 369 · Delaware codifies its gun violence prevention and community safety office · Enacted · Chapter 85:468Delaware Legislature · HB 369
Delaware codifies its gun violence prevention and community safety office
Sep 3, 2026 · Enacted · Chapter 85:468
Rep. Mara Gorman · Sponsored / Sen. S. Elizabeth Lockman · Sponsored / Rep. Eric Morrison · Co-sponsored / Rep. DeShanna U Neal · Co-sponsored / Rep. Nnamdi O. Chukwuocha · Co-sponsored / Rep. Josue O Ortega · Co-sponsored / Rep. Kerri Evelyn Harris · Co-sponsored / Rep. Cyndie Romer · Co-sponsored / Sen. David P. Sokola · Co-sponsored / Sen. Stephanie L. Hansen · Co-sponsored / Sen. Marie Pinkney · Co-sponsored / Sen. Nicole Poore · Co-sponsored
FactVote reviewed summary
HB 369, enacted as Volume 85, Chapter 468, codifies an Office of Gun Violence Prevention and Community Safety within Safety and Homeland Security. It directs intergovernmental coordination, advice on prevention and intervention, recurring-issue reporting and cooperation from relevant state agencies. The office was previously established by EO 9 on May 1, 2025. This statutory milestone does not show a second independent prevention program, a new appropriation, completed interventions or a measured reduction in gun injuries, deaths or crime.
Chapter 85:468 signed 2026-09-03. Signing, effective dates, implementation and current enforceability are distinct.
Why this record is included
HB 369, enacted as Volume 85, Chapter 468, codifies an Office of Gun Violence Prevention and Community Safety within Safety and Homeland Security. It directs intergovernmental coordination, advice on prevention and intervention, recurring-issue reporting and cooperation from relevant state agencies. The office was previously established by EO 9 on May 1, 2025. This statutory milestone does not show a second independent prevention program, a new appropriation, completed interventions or a measured reduction in gun injuries, deaths or crime.
Retained Delaware evidence context: Firearm deaths · Homicide deaths · Reported violent-crime rate · health · reviewed Delaware policy context · crime · reviewed Delaware policy context. This record’s connection to the topic does not establish an effect on the measured result.
There is hereby established, within the Department of Safety and Homeland Security, an Office of Gun Violence Prevention and Community Safety
Inspect this action on the timeline ↑Sep 3, 2026 · HB 369 · Delaware codifies its gun violence prevention and community safety office · Signed · Chapter 85:468Governor · HB 369
Delaware codifies its gun violence prevention and community safety office
Sep 3, 2026 · Signed · Chapter 85:468
Gov. Matt Meyer · Signed
FactVote reviewed summary
HB 369, enacted as Volume 85, Chapter 468, codifies an Office of Gun Violence Prevention and Community Safety within Safety and Homeland Security. It directs intergovernmental coordination, advice on prevention and intervention, recurring-issue reporting and cooperation from relevant state agencies. The office was previously established by EO 9 on May 1, 2025. This statutory milestone does not show a second independent prevention program, a new appropriation, completed interventions or a measured reduction in gun injuries, deaths or crime.
Signed 2026-09-03. Governor approval September 3, 2026. Statutory codification is distinct from EO 9’s May 1, 2025 establishment and from subsequent appointments, program delivery and outcomes.
Why this record is included
HB 369, enacted as Volume 85, Chapter 468, codifies an Office of Gun Violence Prevention and Community Safety within Safety and Homeland Security. It directs intergovernmental coordination, advice on prevention and intervention, recurring-issue reporting and cooperation from relevant state agencies. The office was previously established by EO 9 on May 1, 2025. This statutory milestone does not show a second independent prevention program, a new appropriation, completed interventions or a measured reduction in gun injuries, deaths or crime.
Retained Delaware evidence context: health · reviewed Delaware policy context · crime · reviewed Delaware policy context. This record’s connection to the topic does not establish an effect on the measured result.
There is hereby established, within the Department of Safety and Homeland Security, an Office of Gun Violence Prevention and Community Safety
Inspect this action on the timeline ↑Aug 31, 2026 · SS 1 for SB 161 · Delaware approves the Rick Urey Behavioral Health Treatment Act · Enacted · Chapter 85:461Delaware Legislature · SS 1 for SB 161
Delaware approves the Rick Urey Behavioral Health Treatment Act
Aug 31, 2026 · Enacted · Chapter 85:461
Sen. Marie Pinkney · Sponsored / Rep. Nnamdi O. Chukwuocha · Sponsored / Rep. Krista Griffith · Co-sponsored / Rep. Larry Lambert · Co-sponsored / Rep. DeShanna U Neal · Co-sponsored
Reviewed final state legislation
SS 1 for SB 161, enacted as Volume 85, Chapter 461, revises behavioral-health provider licensing, oversight and enforcement. It establishes client rights and provider duties, incident reporting and investigations, protection-and-advocacy access, confidentiality and remedies. It creates specified offenses for unlawful unlicensed treatment and intentional reporting violations, with civil penalties and anti-retaliation protections. Section 11 makes sections 6, 7 and 10–12 effective immediately. Section 12 also makes sections 1–5, 8 and 9 effective immediately but sets implementation for the earlier of two years after enactment or the Director’s published notice of final implementing regulations. Licensing exemptions and lawful limits on client rights apply. Signing does not prove completed regulations, provider compliance, improved health or reduced crime.
Signed 2026-08-31. Immediate legal effectiveness is distinct from the earlier-of-two-years-or-regulations-notice implementation rule for sections 1–5, 8 and 9.
Why this record is included
SS 1 for SB 161, enacted as Volume 85, Chapter 461, revises behavioral-health provider licensing, oversight and enforcement. It establishes client rights and provider duties, incident reporting and investigations, protection-and-advocacy access, confidentiality and remedies. It creates specified offenses for unlawful unlicensed treatment and intentional reporting violations, with civil penalties and anti-retaliation protections. Section 11 makes sections 6, 7 and 10–12 effective immediately. Section 12 also makes sections 1–5, 8 and 9 effective immediately but sets implementation for the earlier of two years after enactment or the Director’s published notice of final implementing regulations. Licensing exemptions and lawful limits on client rights apply. Signing does not prove completed regulations, provider compliance, improved health or reduced crime. The chart does not isolate this action’s effect.
Retained Delaware evidence context: health · reviewed Delaware policy context · crime · reviewed Delaware policy context. This record’s connection to the topic does not establish an effect on the measured result.
Sections 1 through 5, 8, and 9 of this Act are effective immediately and are to be implemented the earlier of the following:
Records come from published fact relationships or reviewed topic records with official supporting evidence and verified Delaware officeholder attribution. Historical executive officials require evidence tied to the action date and are excluded from incumbent proposals. Inclusion follows an explicit topic review, a related state fact, or the action’s title and supporting evidence. Explicit topic reviews take priority; repeated actions use the most recent explicit review for this topic. Duplicate actions attached to several facts appear once. This topic match is not a new finding that an action caused a result, and the reviewed collection is selective. Collection reviewed Oct 6, 2026.
What candidates are saying
Explore statements about health coverage, healthcare costs, access to care and public health from FactVote’s Delaware candidate profiles. Compare candidates within each recorded race, with each person’s matching statements kept together. These are candidate and campaign statements, not verified outcomes.
38 statements from 8 candidates
2026 Delaware State Treasurer — Democratic Primary
1 candidate with matching statements · 2 statements
Ensure that our state stands ready in the face of any future federal funding disruptions, particularly for big-budget items like Medicaid, SNAP, transportation, and education
Read exact statement & source
Source topic or question: Health care
Candidate campaign source
Ensure that our state stands ready in the face of any future federal funding disruptions, particularly for big-budget items like Medicaid, SNAP, transportation, and education
Statement date not recorded · Profile reviewed Sep 15, 2026
Health care is a human right. In the wealthiest nation on earth, any person left without health coverage is a moral failing. In Congress, I will support any positive policy that advances our country toward the ultimate goal of universal coverage. At a minimum, we should expand Medicare to cover dent…
Read exact statement & source
Source topic or question: Health care
Candidate campaign source
Health care is a human right. In the wealthiest nation on earth, any person left without health coverage is a moral failing. In Congress, I will support any positive policy that advances our country toward the ultimate goal of universal coverage. At a minimum, we should expand Medicare to cover dental, vision, and hearing while lowering the age of eligibility and providing a public option.
Statement date not recorded · Profile reviewed Sep 15, 2026
It is so important that we shed light on the importance of reproductive health and maternal health, especially for women of color. We must take decisive action to bridge the gap in health disparities here at home and around the world. In 2022, I helped expand Medicaid coverage for post-pregnancy car…
Read exact statement & source
Source topic or question: Reproductive rights
Candidate campaign source
It is so important that we shed light on the importance of reproductive health and maternal health, especially for women of color. We must take decisive action to bridge the gap in health disparities here at home and around the world. In 2022, I helped expand Medicaid coverage for post-pregnancy care. In Congress, I will be a staunch advocate for coverage, including through Medicaid, for the full range of reproductive health care patients need and to end draconian policies like the global gag rule that limit funds internationally in reproductive health care.
Statement date not recorded · Profile reviewed Sep 15, 2026
From nurses and physician assistants to dentists and physicians, health care providers are the backbone of our health care system. Everyone should be able to access a quality provider near them, regardless of whether you live in a small town in Sussex or just north of Wilmington. As I have successfu…
Read exact statement & source
Source topic or question: Health care
Candidate campaign source
From nurses and physician assistants to dentists and physicians, health care providers are the backbone of our health care system. Everyone should be able to access a quality provider near them, regardless of whether you live in a small town in Sussex or just north of Wilmington. As I have successfully done in the legislature, I will support our health care workforce by bringing investments to Delaware for education and career support.
Statement date not recorded · Profile reviewed Sep 15, 2026
Chris believes everyone should have access to quality, affordable health care, which is why he has fought against Trump’s threats to the Affordable Care Act and Medicaid. He has also worked to protect Delaware’s hospitals, reduce overcrowding in Emergency Departments, and increase access to innovati…
Read exact statement & source
Source topic or question: Health care
Candidate campaign source
Chris believes everyone should have access to quality, affordable health care, which is why he has fought against Trump’s threats to the Affordable Care Act and Medicaid. He has also worked to protect Delaware’s hospitals, reduce overcrowding in Emergency Departments, and increase access to innovative treatments.
Statement date not recorded · Profile reviewed Sep 17, 2026
As a senior member of the Senate Judiciary Committee, Chris is committed to pushing back on the Trump Administration’s attempts to weaponize the Department of Justice, install extreme and unqualified judges, and create a system that works for the few at the expense of the many. Chris is also a fierc…
Read exact statement & source
Source topic or question: Reproductive rights
Candidate campaign source
As a senior member of the Senate Judiciary Committee, Chris is committed to pushing back on the Trump Administration’s attempts to weaponize the Department of Justice, install extreme and unqualified judges, and create a system that works for the few at the expense of the many. Chris is also a fierce defender of our constitutional rights, including protecting access to reproductive health care.
Statement date not recorded · Profile reviewed Sep 17, 2026
As your United States Senator, I will support equal rights protections that ensure every American is treated fairly under the law, including protections against discrimination in employment, housing, education, healthcare, public accommodations, and other areas of daily life. I believe our laws shou…
Read exact statement & source
Source topic or question: Civil rights and individual freedom
Candidate campaign source
As your United States Senator, I will support equal rights protections that ensure every American is treated fairly under the law, including protections against discrimination in employment, housing, education, healthcare, public accommodations, and other areas of daily life. I believe our laws should safeguard equal opportunity while respecting the fundamental freedoms guaranteed by our Constitution.
Statement date not recorded · Profile reviewed Sep 15, 2026
Encourage broader access to evidence-based integrative healthcare services when supported by scientific research and shown to improve patient outcomes.
Read exact statement & source
Source topic or question: Health care
Candidate campaign source
Encourage broader access to evidence-based integrative healthcare services when supported by scientific research and shown to improve patient outcomes.
Statement date not recorded · Profile reviewed Sep 15, 2026
This section matches specific health coverage, healthcare costs, access to care and public health terms in retained, attributed source text from published Delaware candidate profiles. A profile heading or biography alone does not qualify. The Florida geography is fixed; saved state preferences cannot change these results. A mention can concern a community or group rather than Florida’s statewide measure.
Matching is automatic and does not establish a candidate’s stance, the accuracy of a claim, or an effect on the measured result. Results are grouped by recorded race, then by candidate name. Within each candidate, the matching issue mentions appear first. Only candidates with matching retained statements are shown; this is not a complete race roster. Repeated identical text for the same candidate is shown once. Coverage follows the existing state profiles and is not a complete record of all candidates or everything they have said. Review dates are not statement dates.
Delaware incumbents
What incumbents are proposing
Explore reviewed bills sponsored by current Delaware legislators and Delaware’s congressional delegation, plus retained proposals from Delaware’s governor and agencies. Each record keeps its latest recorded status and official evidence.
12 matching sponsorships or proposals · 9 Delaware incumbents. These filters apply only to this section.
Rep. Debra Heffernan
Delaware House of Representatives · D–DE
1 proposalView proposals from Rep. Debra HeffernanDelaware Legislature · HS 2 for HB 110
Delaware approves insurance coverage for pregnancy-termination services
Sep 9, 2024 · Enacted · Chapter 84:402
Rep. Melissa Minor-Brown · Sponsored / Rep. Debra Heffernan · Sponsored / Rep. William Bush · Sponsored / Sen. Bryan Townsend · Sponsored / Rep. Kendra Johnson · Co-sponsored / Rep. Eric Morrison · Co-sponsored / Rep. DeShanna U Neal · Co-sponsored / Rep. Cyndie Romer · Co-sponsored / Sen. David P. Sokola · Co-sponsored / Sen. Kyra L. Hoffner · Co-sponsored / Sen. Marie Pinkney · Co-sponsored / Sen. Stephanie L. Hansen · Co-sponsored
FactVote reviewed summary
HS 2 for HB 110, enacted as Volume 84, Chapter 402, requires specified Medicaid, private-insurance and state-employee plans to cover lawful pregnancy-termination services. Medicaid coverage has a $750 annual per-person maximum; specified private plans may apply that cap. Covered services generally have no cost sharing, with express federal-plan-status exceptions. Medicaid services use federal funds when permitted and state funds otherwise. Medicaid and state-employee provisions start January 1, 2025. Private-policy applicability follows issuance, renewal or specified policy changes after December 31, 2025. Plan coverage, network requirements, eligible religious-employer exclusions and federal-plan-status exceptions remain. Approval does not establish care delivered, actual program spending or improved health outcomes.
Chapter 84:402 signed 2024-09-09. Signing, effective dates, implementation and current enforceability are distinct.
Why this record is included
HS 2 for HB 110, enacted as Volume 84, Chapter 402, requires specified Medicaid, private-insurance and state-employee plans to cover lawful pregnancy-termination services. Medicaid coverage has a $750 annual per-person maximum; specified private plans may apply that cap. Covered services generally have no cost sharing, with express federal-plan-status exceptions. Medicaid services use federal funds when permitted and state funds otherwise. Medicaid and state-employee provisions start January 1, 2025. Private-policy applicability follows issuance, renewal or specified policy changes after December 31, 2025. Plan coverage, network requirements, eligible religious-employer exclusions and federal-plan-status exceptions remain. Approval does not establish care delivered, actual program spending or improved health outcomes.
Retained Delaware evidence context: Abortions reported by area of occurrence · health · reviewed Delaware policy context · deficit-debt-interest · reviewed Delaware policy context. This record’s connection to the topic does not establish an effect on the measured result.
Sections 1 and 5 of this Act take effect January 1 of the year following enactment.
1 proposalView proposals from Rep. Krista GriffithDelaware Legislature · SJR 6
Delaware directs a study of prenatal and postpartum coverage options
Jun 24, 2025 · Signed joint resolution
Sen. Marie Pinkney · Sponsored / Rep. Krista Griffith · Sponsored / Sen. S. Elizabeth Lockman · Co-sponsored / Sen. David P. Sokola · Co-sponsored / Rep. Debra Heffernan · Co-sponsored / Rep. Eric Morrison · Co-sponsored / Rep. DeShanna U Neal · Co-sponsored / Rep. Cyndie Romer · Co-sponsored / Rep. Melanie Ross Levin · Co-sponsored / Rep. Claire Snyder-Hall · Co-sponsored
FactVote reviewed summary
SJR 6 directs Medicaid and Medical Assistance officials to explore the CHIP From-Conception-to-End-of-Pregnancy option and a CHIP Health Services Initiative for postpartum coverage for people otherwise ineligible because of immigration status. It requires conclusions, analysis, relevant findings and projected implementation costs in a report due by January 1, 2026. This signed resolution requires exploration and a report; it does not enact expanded enrollment or establish submitted reports, federal approvals, delivered coverage or improved maternal and infant outcomes. The deadline passing does not prove report delivery.
Joint resolution signed 2025-06-24. Signing, effective dates, implementation and current enforceability are distinct.
Why this record is included
SJR 6 directs Medicaid and Medical Assistance officials to explore the CHIP From-Conception-to-End-of-Pregnancy option and a CHIP Health Services Initiative for postpartum coverage for people otherwise ineligible because of immigration status. It requires conclusions, analysis, relevant findings and projected implementation costs in a report due by January 1, 2026. This signed resolution requires exploration and a report; it does not enact expanded enrollment or establish submitted reports, federal approvals, delivered coverage or improved maternal and infant outcomes. The deadline passing does not prove report delivery.
Retained Delaware evidence context: People under 65 without health insurance · Residents who are foreign-born · health · reviewed Delaware policy context. This record’s connection to the topic does not establish an effect on the measured result.
DMMA is directed to explore creation of a CHIP Health Services Initiative (HSI) to expand postpartum coverage
1 proposalView proposals from Rep. Mara GormanDelaware Legislature · HB 369
Delaware codifies its gun violence prevention and community safety office
Sep 3, 2026 · Enacted · Chapter 85:468
Rep. Mara Gorman · Sponsored / Sen. S. Elizabeth Lockman · Sponsored / Rep. Eric Morrison · Co-sponsored / Rep. DeShanna U Neal · Co-sponsored / Rep. Nnamdi O. Chukwuocha · Co-sponsored / Rep. Josue O Ortega · Co-sponsored / Rep. Kerri Evelyn Harris · Co-sponsored / Rep. Cyndie Romer · Co-sponsored / Sen. David P. Sokola · Co-sponsored / Sen. Stephanie L. Hansen · Co-sponsored / Sen. Marie Pinkney · Co-sponsored / Sen. Nicole Poore · Co-sponsored
FactVote reviewed summary
HB 369, enacted as Volume 85, Chapter 468, codifies an Office of Gun Violence Prevention and Community Safety within Safety and Homeland Security. It directs intergovernmental coordination, advice on prevention and intervention, recurring-issue reporting and cooperation from relevant state agencies. The office was previously established by EO 9 on May 1, 2025. This statutory milestone does not show a second independent prevention program, a new appropriation, completed interventions or a measured reduction in gun injuries, deaths or crime.
Chapter 85:468 signed 2026-09-03. Signing, effective dates, implementation and current enforceability are distinct.
Why this record is included
HB 369, enacted as Volume 85, Chapter 468, codifies an Office of Gun Violence Prevention and Community Safety within Safety and Homeland Security. It directs intergovernmental coordination, advice on prevention and intervention, recurring-issue reporting and cooperation from relevant state agencies. The office was previously established by EO 9 on May 1, 2025. This statutory milestone does not show a second independent prevention program, a new appropriation, completed interventions or a measured reduction in gun injuries, deaths or crime.
Retained Delaware evidence context: Firearm deaths · Homicide deaths · Reported violent-crime rate · health · reviewed Delaware policy context · crime · reviewed Delaware policy context. This record’s connection to the topic does not establish an effect on the measured result.
There is hereby established, within the Department of Safety and Homeland Security, an Office of Gun Violence Prevention and Community Safety
1 proposalView proposals from Rep. Melissa Minor-BrownDelaware Legislature · HS 2 for HB 110
Delaware approves insurance coverage for pregnancy-termination services
Sep 9, 2024 · Enacted · Chapter 84:402
Rep. Melissa Minor-Brown · Sponsored / Rep. Debra Heffernan · Sponsored / Rep. William Bush · Sponsored / Sen. Bryan Townsend · Sponsored / Rep. Kendra Johnson · Co-sponsored / Rep. Eric Morrison · Co-sponsored / Rep. DeShanna U Neal · Co-sponsored / Rep. Cyndie Romer · Co-sponsored / Sen. David P. Sokola · Co-sponsored / Sen. Kyra L. Hoffner · Co-sponsored / Sen. Marie Pinkney · Co-sponsored / Sen. Stephanie L. Hansen · Co-sponsored
FactVote reviewed summary
HS 2 for HB 110, enacted as Volume 84, Chapter 402, requires specified Medicaid, private-insurance and state-employee plans to cover lawful pregnancy-termination services. Medicaid coverage has a $750 annual per-person maximum; specified private plans may apply that cap. Covered services generally have no cost sharing, with express federal-plan-status exceptions. Medicaid services use federal funds when permitted and state funds otherwise. Medicaid and state-employee provisions start January 1, 2025. Private-policy applicability follows issuance, renewal or specified policy changes after December 31, 2025. Plan coverage, network requirements, eligible religious-employer exclusions and federal-plan-status exceptions remain. Approval does not establish care delivered, actual program spending or improved health outcomes.
Chapter 84:402 signed 2024-09-09. Signing, effective dates, implementation and current enforceability are distinct.
Why this record is included
HS 2 for HB 110, enacted as Volume 84, Chapter 402, requires specified Medicaid, private-insurance and state-employee plans to cover lawful pregnancy-termination services. Medicaid coverage has a $750 annual per-person maximum; specified private plans may apply that cap. Covered services generally have no cost sharing, with express federal-plan-status exceptions. Medicaid services use federal funds when permitted and state funds otherwise. Medicaid and state-employee provisions start January 1, 2025. Private-policy applicability follows issuance, renewal or specified policy changes after December 31, 2025. Plan coverage, network requirements, eligible religious-employer exclusions and federal-plan-status exceptions remain. Approval does not establish care delivered, actual program spending or improved health outcomes.
Retained Delaware evidence context: Abortions reported by area of occurrence · health · reviewed Delaware policy context · deficit-debt-interest · reviewed Delaware policy context. This record’s connection to the topic does not establish an effect on the measured result.
Sections 1 and 5 of this Act take effect January 1 of the year following enactment.
2 proposalsView proposals from Rep. Nnamdi O. ChukwuochaDelaware Legislature · SB 249
Delaware approves harm-reduction licensing and personal-use paraphernalia changes
Sep 30, 2026 · Enacted · Chapter 85:536
Sen. Marie Pinkney · Sponsored / Rep. Nnamdi O. Chukwuocha · Sponsored / Sen. Ray Seigfried · Co-sponsored / Sen. David P. Sokola · Co-sponsored / Sen. Laura V. Sturgeon · Co-sponsored / Rep. Alonna Berry · Co-sponsored / Rep. Stephanie T. Bolden · Co-sponsored / Rep. Kendra Johnson · Co-sponsored / Rep. Larry Lambert · Co-sponsored / Rep. Eric Morrison · Co-sponsored / Rep. DeShanna U Neal · Co-sponsored / Rep. Cyndie Romer · Co-sponsored / Rep. Kamela T Smith · Co-sponsored
Reviewed final state legislation
Final amended SB 249, enacted as Volume 85, Chapter 536, establishes evidence-based licensing for harm-reduction providers, required supplies and services, participant anonymity, limited program data collection, referrals and conditional good-faith immunity. It revises drug-paraphernalia definitions and exempts specified personal-use, storage, testing and consumption supplies while retaining manufacturing, distribution and specified sales prohibitions. Signing and the bill page’s September 30 effective date are distinct from licensing regulations, provider licenses and service delivery. Immunity requires good faith and reasonable care and has express misconduct exceptions. Referrals do not guarantee housing, benefits or treatment, and the act does not decriminalize all drug possession or establish lower overdose deaths or crime rates.
Signed 2026-09-30. The final text establishes the licensing authority; actual regulations, licenses, program operations and outcomes require separate verification.
Why this record is included
Final amended SB 249, enacted as Volume 85, Chapter 536, establishes evidence-based licensing for harm-reduction providers, required supplies and services, participant anonymity, limited program data collection, referrals and conditional good-faith immunity. It revises drug-paraphernalia definitions and exempts specified personal-use, storage, testing and consumption supplies while retaining manufacturing, distribution and specified sales prohibitions. Signing and the bill page’s September 30 effective date are distinct from licensing regulations, provider licenses and service delivery. Immunity requires good faith and reasonable care and has express misconduct exceptions. Referrals do not guarantee housing, benefits or treatment, and the act does not decriminalize all drug possession or establish lower overdose deaths or crime rates. The chart does not isolate this action’s effect.
Retained Delaware evidence context: health · reviewed Delaware policy context · crime · reviewed Delaware policy context. This record’s connection to the topic does not establish an effect on the measured result.
A program must not require a one-for-one exchange of sterile supplies.
Delaware approves the Rick Urey Behavioral Health Treatment Act
Aug 31, 2026 · Enacted · Chapter 85:461
Sen. Marie Pinkney · Sponsored / Rep. Nnamdi O. Chukwuocha · Sponsored / Rep. Krista Griffith · Co-sponsored / Rep. Larry Lambert · Co-sponsored / Rep. DeShanna U Neal · Co-sponsored
Reviewed final state legislation
SS 1 for SB 161, enacted as Volume 85, Chapter 461, revises behavioral-health provider licensing, oversight and enforcement. It establishes client rights and provider duties, incident reporting and investigations, protection-and-advocacy access, confidentiality and remedies. It creates specified offenses for unlawful unlicensed treatment and intentional reporting violations, with civil penalties and anti-retaliation protections. Section 11 makes sections 6, 7 and 10–12 effective immediately. Section 12 also makes sections 1–5, 8 and 9 effective immediately but sets implementation for the earlier of two years after enactment or the Director’s published notice of final implementing regulations. Licensing exemptions and lawful limits on client rights apply. Signing does not prove completed regulations, provider compliance, improved health or reduced crime.
Signed 2026-08-31. Immediate legal effectiveness is distinct from the earlier-of-two-years-or-regulations-notice implementation rule for sections 1–5, 8 and 9.
Why this record is included
SS 1 for SB 161, enacted as Volume 85, Chapter 461, revises behavioral-health provider licensing, oversight and enforcement. It establishes client rights and provider duties, incident reporting and investigations, protection-and-advocacy access, confidentiality and remedies. It creates specified offenses for unlawful unlicensed treatment and intentional reporting violations, with civil penalties and anti-retaliation protections. Section 11 makes sections 6, 7 and 10–12 effective immediately. Section 12 also makes sections 1–5, 8 and 9 effective immediately but sets implementation for the earlier of two years after enactment or the Director’s published notice of final implementing regulations. Licensing exemptions and lawful limits on client rights apply. Signing does not prove completed regulations, provider compliance, improved health or reduced crime. The chart does not isolate this action’s effect.
Retained Delaware evidence context: health · reviewed Delaware policy context · crime · reviewed Delaware policy context. This record’s connection to the topic does not establish an effect on the measured result.
Sections 1 through 5, 8, and 9 of this Act are effective immediately and are to be implemented the earlier of the following:
1 proposalView proposals from Rep. William BushDelaware Legislature · HS 2 for HB 110
Delaware approves insurance coverage for pregnancy-termination services
Sep 9, 2024 · Enacted · Chapter 84:402
Rep. Melissa Minor-Brown · Sponsored / Rep. Debra Heffernan · Sponsored / Rep. William Bush · Sponsored / Sen. Bryan Townsend · Sponsored / Rep. Kendra Johnson · Co-sponsored / Rep. Eric Morrison · Co-sponsored / Rep. DeShanna U Neal · Co-sponsored / Rep. Cyndie Romer · Co-sponsored / Sen. David P. Sokola · Co-sponsored / Sen. Kyra L. Hoffner · Co-sponsored / Sen. Marie Pinkney · Co-sponsored / Sen. Stephanie L. Hansen · Co-sponsored
FactVote reviewed summary
HS 2 for HB 110, enacted as Volume 84, Chapter 402, requires specified Medicaid, private-insurance and state-employee plans to cover lawful pregnancy-termination services. Medicaid coverage has a $750 annual per-person maximum; specified private plans may apply that cap. Covered services generally have no cost sharing, with express federal-plan-status exceptions. Medicaid services use federal funds when permitted and state funds otherwise. Medicaid and state-employee provisions start January 1, 2025. Private-policy applicability follows issuance, renewal or specified policy changes after December 31, 2025. Plan coverage, network requirements, eligible religious-employer exclusions and federal-plan-status exceptions remain. Approval does not establish care delivered, actual program spending or improved health outcomes.
Chapter 84:402 signed 2024-09-09. Signing, effective dates, implementation and current enforceability are distinct.
Why this record is included
HS 2 for HB 110, enacted as Volume 84, Chapter 402, requires specified Medicaid, private-insurance and state-employee plans to cover lawful pregnancy-termination services. Medicaid coverage has a $750 annual per-person maximum; specified private plans may apply that cap. Covered services generally have no cost sharing, with express federal-plan-status exceptions. Medicaid services use federal funds when permitted and state funds otherwise. Medicaid and state-employee provisions start January 1, 2025. Private-policy applicability follows issuance, renewal or specified policy changes after December 31, 2025. Plan coverage, network requirements, eligible religious-employer exclusions and federal-plan-status exceptions remain. Approval does not establish care delivered, actual program spending or improved health outcomes.
Retained Delaware evidence context: Abortions reported by area of occurrence · health · reviewed Delaware policy context · deficit-debt-interest · reviewed Delaware policy context. This record’s connection to the topic does not establish an effect on the measured result.
Sections 1 and 5 of this Act take effect January 1 of the year following enactment.
Only current Delaware officeholders retained in the reviewed collection qualify. Bills require a recorded primary sponsorship; cosponsors and signing officials are excluded from sponsorship counts. An official introducer recorded as acting by request is labeled “Introduced by request”; that procedural role does not establish personal policy endorsement. Governor and agency records qualify when recorded as proposed. A separately verified governor transmittal can also establish an original proposal whose latest status reflects its later outcome. Signing an enacted law alone does not establish a proposal. A record appearing under several facts is counted once per officeholder. A bill with multiple primary sponsors appears under each recorded sponsor.
Enacted bills, adopted resolutions and unsuccessful measures remain visible as proposal history. Passing one chamber is not enactment. These counts do not measure effectiveness or prove that an action changed a Delaware statistic. Collection reviewed Oct 6, 2026.
Sources & methods
Every section retains its primary sources, units, reporting periods and comparison limits. Maps, graphs and tables use the same observation and cohort. All 50 states are listed; D.C. and territories are excluded. Missing and suppressed values remain unavailable and never become zero.
#1 is the highest measured value. Equal source values share a rank and leave gaps (1, 2, 2, 4). Ranks use source precision and are descriptive, not a score of the state. Survey uncertainty and reporting coverage can limit comparisons. Published U.S. benchmarks are used where available; a state average is not substituted.
Delaware snapshots and fiscal sources keep their own dates and accounting scope. National events and federal distribution explainers describe national context. Actions and statements are filtered to Delaware, retain their reviewed evidence, and do not establish that a policy caused a measured change.
Retained state source collections assembled October 5, 2026. Original review and source dates remain visible. Refreshing this page does not refresh an official data release.